Breast Cancer
Navelbine(Vinorelbine) – NSCLC | HongKong DengYue Medicine
Qingweishi (Everolimus) – Oncology | HongKong DengYue Medicine
Phesgo (Pertuzumab/Trastuzumab) – HER2-Positive | HongKong DengYue Medicine
Kropsen (Proxalutamide) – mCRPC | HongKong DengYue Medicine
Margenza (Margetuximab) – HER2 | HongKong DengYue Medicine
Verzenio (Abemaciclib) – Breast Cancer | HongKong DengYue Medicine
Rujianing (Lerociclib) – Breast Cancer | HongKong DengYue Medicine
Kangmeina (Tibremciclib) – Breast Cancer | HongKong DengYue Medicine
Futuoning (Fovinaciclib) – Breast Cancer | HongKong DengYue Medicine
Xuanyuening (Birociclib) – Breast Cancer | HongKong DengYue Medicine
Nerlynx (Neratinib) – HER2 | HongKong DengYue Medicine
TRODELVY (Sacituzumab Govitecan) – mTNBC | HongKong DengYue Medicine
Entinostat Tablets – HDAC | HongKong DengYue Medicine
ENHERTU (Trastuzumab Deruxtecan) – HER2-driven cancers | HongKong DengYue Medicine
Herceptin (Trastuzumab) – Breast Cancer | HongKong DengYue Medicine
Kisqali (Ribociclib) – Breast Cancer | HongKong DengYue Medicine
